Diabetes Treatment With Glucobay in Combination With Sulfonylurea
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
In this prospective, non interventional, observational Post Marketing Survelliance study data
are obtained on the efficacy, safety and tolerability of Glucobay treatment on top of
sulfonylurea under daily life treatment conditions.Specifically investigated is the influence
of Glucobay on Post Prandial Blood Glucose and HbA1c as well as on pateint's weight when
added to an already existing sulfonylurea therapy.The study is planned to carried out in
25000 - 30000 patients from 200 trial sites in India.The Post Marketing Survelliance study
will be performed with commercially available medication prescribed within regular practice
of the physician. No other examination will be performed than would be done without Post
Marketing Survelliance study.